199 related articles for article (PubMed ID: 31872048)
1. Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.
Barcia G; Chemaly N; Kuchenbuch M; Eisermann M; Gobin-Limballe S; Ciorna V; Macaya A; Lambert L; Dubois F; Doummar D; Billette de Villemeur T; Villeneuve N; Barthez MA; Nava C; Boddaert N; Kaminska A; Bahi-Buisson N; Milh M; Auvin S; Bonnefont JP; Nabbout R
Neurol Genet; 2019 Dec; 5(6):e363. PubMed ID: 31872048
[TBL] [Abstract][Full Text] [Related]
2. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
[TBL] [Abstract][Full Text] [Related]
3. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
[TBL] [Abstract][Full Text] [Related]
4. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
[TBL] [Abstract][Full Text] [Related]
5. [Early infantile epileptic encephalopathy type 14: three cases of epilepsy in infancy with migrating focal seizures due to KCNT1 mutations].
Kholin AA; Zavadenko NN; Fedonyuk ID; Antonets AV; Mukhin KY; Malov AG; Vshivkov MI; Anisimov GV; Il'ina ES
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7. Vyp. 2):74-82. PubMed ID: 31532594
[TBL] [Abstract][Full Text] [Related]
6. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
[TBL] [Abstract][Full Text] [Related]
7. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterization of
McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures.
Kuchenbuch M; Benquet P; Kaminska A; Roubertie A; Carme E; de Saint Martin A; Hirsch E; Dubois F; Laroche C; Barcia G; Chemaly N; Milh M; Villeneuve N; Sauleau P; Modolo J; Wendling F; Nabbout R
Epilepsia; 2019 Jan; 60(1):20-32. PubMed ID: 30525185
[TBL] [Abstract][Full Text] [Related]
10. De novo KCNT1 mutations in early-onset epileptic encephalopathy.
Ohba C; Kato M; Takahashi N; Osaka H; Shiihara T; Tohyama J; Nabatame S; Azuma J; Fujii Y; Hara M; Tsurusawa R; Inoue T; Ogata R; Watanabe Y; Togashi N; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
Epilepsia; 2015 Sep; 56(9):e121-8. PubMed ID: 26140313
[TBL] [Abstract][Full Text] [Related]
11. A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.
Ishii A; Shioda M; Okumura A; Kidokoro H; Sakauchi M; Shimada S; Shimizu T; Osawa M; Hirose S; Yamamoto T
Gene; 2013 Dec; 531(2):467-71. PubMed ID: 24029078
[TBL] [Abstract][Full Text] [Related]
12. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
[TBL] [Abstract][Full Text] [Related]
13. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
[TBL] [Abstract][Full Text] [Related]
14. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
Datta AN; Michoulas A; Guella I; ; Demos M
J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
[No Abstract] [Full Text] [Related]
15. Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy.
Kravetz MC; Viola MS; Prenz J; Curi M; Bramuglia GF; Tenembaum S
Front Pharmacol; 2021; 12():648519. PubMed ID: 34122071
[No Abstract] [Full Text] [Related]
16. Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
Yoshitomi S; Takahashi Y; Yamaguchi T; Oboshi T; Horino A; Ikeda H; Imai K; Okanishi T; Nakashima M; Saitsu H; Matsumoto N; Yoshimoto J; Fujita T; Ishii A; Hirose S; Inoue Y
Epileptic Disord; 2019 Feb; 21(1):48-54. PubMed ID: 30782581
[TBL] [Abstract][Full Text] [Related]
17. [Genetic and clinical analysis of children with early-onset epilepsy encephalopathy caused by KCNT1 gene mutation].
Chen Y; Bao XH; Zhang QP; Wang JP; Wen YX; Yu SJ; Zhao Y
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):824-828. PubMed ID: 30392206
[No Abstract] [Full Text] [Related]
18. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.
Poisson K; Wong M; Lee C; Cilio MR
Eur J Paediatr Neurol; 2020 Mar; 25():77-81. PubMed ID: 31926846
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features and gene mutations in epilepsy of infancy with migrating focal seizures].
Shang KW; Zhang YH; Yang XL; Liu AJ; Yang ZX; Liu XY; Jiang YW; Wu XR
Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):735-739. PubMed ID: 27784474
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]